Meituan Unsponsored ADR MPNGY
—
18.18
(0.09)
(0.49%)
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow MPNGY
Growth Flags
show if company had growth for consecutive years
| Sep '25 | Jun '25 | Mar '25 | Dec '24 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.61 | 1.95 | 2.55 | 2.54 | |
P/FCF ratio |
5.26 | 6.35 | 7.54 | 7.25 | |
P/Operating CF |
39.25 | 47.35 | 15.62 | 15.03 | |
P/B ratio |
3.46 | 3.83 | 4.91 | 4.98 | |
Price to Tangible BV |
4.22 | 4.58 | 5.88 | 6.03 | |
EV/Sales |
1.25 | 1.52 | 2.12 | 2.11 | |
EV/EBITDA |
0.00 | 17.52 | 17.59 | 19.36 | |
EV/Operating CF |
3.26 | 3.95 | 5.19 | 5.00 | |
EV/FCF |
4.08 | 4.93 | 6.24 | 6.02 | |
Quick Ratio |
1.42 | 1.71 | 1.90 | 1.76 | |
Current Ratio |
1.71 | 1.93 | 2.09 | 1.94 | |
Net Debt/EBITDA |
6.61 | (694.15) | (14.68) | (21.70) | |
Debt/Assets |
10.14% | 9.64% | 12.75% | 13.05% | |
Debt/Equity |
0.19 | 0.17 | 0.23 | 0.25 | |
Asset Turnover |
1.19 | 1.17 | 1.13 | 1.09 | |
Operating CF/Net income |
0.00 | 40.80 | 0.00 | 9.17 | |
Capex/Depreciation |
— | 0.00 | — | (1.20) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
7.26% | 6.82% | 6.67% | 6.13% | |
Selling, General and Administrative Expense of Revenue |
38.98% | 27.44% | 21.00% | 22.87% | |
Intangible Assets out of Total Assets |
0.10 | 0.09 | 0.09 | 0.09 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 8.58% | |
Graham Net Nets |
0.08 | 0.10 | 0.08 | 0.07 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(5.03%) | (4.17%) | (3.80%) | (3.95%) | |
Free Cash Flow Yield |
19.00% | 15.75% | 13.27% | 13.79% | |
Revenue per Share |
0.00 | 4.19 | 0.00 | 0.00 | |
Operating CF per Share |
— | 0.68 | — | 0.00 | |
Capex per Share |
— | (0.24) | — | 0.00 | |
Free Cash Flow per Share |
— | 0.44 | — | 0.00 | |
Cash per Share |
0.00 | 8.62 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 8.40 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 8.40 | 0.00 | 0.00 | |
Free Cash Flow |
— | 1,321.72 | — | 6,543.89 | |
Working Capital |
11,554.66 | 14,499.25 | 15,806.13 | 14,160.27 | |
Capital Expenditures |
— | (738.09) | — | (1,405.23) | |
Net Current Asset Value |
6,825.58 | 9,880.30 | 9,734.12 | 8,065.58 | |
EV/EBIT |
0.00 | 17.52 | 17.59 | 19.36 | |
Capex to Sales |
0.00 | 0.06 | 0.00 | 0.11 | |
Net Profit Margin |
(19.51%) | 0.40% | 11.62% | 7.05% | |
Price to Operating Income |
0.00 | 22.54 | 21.23 | 23.31 | |
| Other line items | |||||
Average Receivables |
468.94 | 419.69 | 408.97 | 378.31 | |
Average Payables |
3,806.34 | 3,611.02 | 3,160.81 | 3,375.76 | |
Average Inventory |
341.04 | 269.72 | 224.23 | 212.78 | |
Average Assets |
42,172.36 | 42,534.50 | 42,869.72 | 43,261.43 | |
Average Common Equity |
22,877.88 | 23,817.44 | 23,598.35 | 22,740.33 |
Columns are period end dates